rs57499817
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_000424.4(KRT5):c.74C>T(p.Pro25Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000027 ( 0 hom. )
Consequence
KRT5
NM_000424.4 missense
NM_000424.4 missense
Scores
3
6
10
Clinical Significance
Conservation
PhyloP100: 3.08
Genes affected
KRT5 (HGNC:6442): (keratin 5) The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Mutations in these genes have been associated with a complex of diseases termed epidermolysis bullosa simplex. The type II cytokeratins are clustered in a region of chromosome 12q12-q13. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.775
PP5
Variant 12-52520223-G-A is Pathogenic according to our data. Variant chr12-52520223-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 14648.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-52520223-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRT5 | NM_000424.4 | c.74C>T | p.Pro25Leu | missense_variant | 1/9 | ENST00000252242.9 | NP_000415.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRT5 | ENST00000252242.9 | c.74C>T | p.Pro25Leu | missense_variant | 1/9 | 1 | NM_000424.4 | ENSP00000252242 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461762Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727186
GnomAD4 exome
AF:
AC:
4
AN:
1461762
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
727186
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2Other:1
not provided, no classification provided | literature only | Epithelial Biology; Institute of Medical Biology, Singapore | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 04, 2020 | Published functional studies demonstrate that although P25L does not interfere with alignment and assembly of keratin intermediate filaments, it affects the length and uniformity of the resulting filaments, thus explaining the milder blistering phenotype of EBS-MP (Uttam et al., 1996); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect, although this variant resides within the non-helical variable head domain (V1 region) of keratin 5, which is outside the typical keratin hot spots; The majority of missense variants in this gene are considered pathogenic (Stenson et al., 2014); Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 31001817, 30690752, 16581562, 22640275, 21623745, 21375516, 20199538, 20923750, 8799157, 16882168, 16098032, 15827748, 11167681, 10494094, 9129237, 26286811, 15030360, 24964947, 22161089, 23889190, 17229601) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 10, 2024 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 25 of the KRT5 protein (p.Pro25Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant epidermolysis bullosa simplex (PMID: 8799157, 15030360, 16098032, 16581562, 17229601). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Pro24Leu. ClinVar contains an entry for this variant (Variation ID: 14648). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KRT5 protein function with a negative predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
Epidermolysis bullosa simplex with mottled pigmentation Pathogenic:1Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2010 | - - |
KRT5-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 30, 2024 | The KRT5 c.74C>T variant is predicted to result in the amino acid substitution p.Pro25Leu. This variant has been reported in individuals with epidermolysis bullosa simplex (EBS) and the affected family members (see for example, Uttam et al. 1996. PubMed ID: 8799157, reported as P24L; Pascucci et al. 2006. PubMed ID: 17229601; Pfendner et al. 2005. PubMed ID: 16098032; Mariath et al. 2019. PubMed ID: 31001817). This variant has also been reported as de novo in an individual with EBS (Table S1, Chen et al. 2023. PubMed ID: 36287101). This variant has not been reported in a large population database, indicating it is rare. This variant is interpreted as pathogenic. - |
Epidermolysis bullosa simplex Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Biomedical Innovation Departament, CIEMAT | Feb 26, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.
MutationTaster
Benign
A
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D
REVEL
Uncertain
Sift
Benign
T;T;D
Sift4G
Benign
T;T;T
Polyphen
B;.;.
Vest4
MutPred
Gain of sheet (P = 0.0028);Gain of sheet (P = 0.0028);Gain of sheet (P = 0.0028);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at